What it is
The genes behind immune resistance and sensitivity.
The CRISPR Cancer Immune Atlas brings together 71 screens across 10 datasets that interrogate how cancer cells evade — or succumb to — immune attack, harmonized for direct comparison.
It spans genome-wide knockout, CRISPR inhibition and activation, and phenotypic screens, under both in vitro immune challenges (CD8⁺ T cells, NK cells) and in vivo models (immunocompromised and immune-active mice) — all connected into CURIE.